cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents Small Molecule CD38 Inhibitors: Synthesis
Small Molecule CD38 Inhibitors: Synthesis of 8 Amino N1 inosine 5 monophosphate, Analogues and Early Structure Activity Relationship Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide induced microglial and astrocytic neuroinflammation by increasing NAD+ PMC Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect CD38 expressing macrophages drive age related NAD+ decline Nature Metabolism The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




